Pricing
Login
Home
Charts
Search
Watchlist
Products

Shilpa Medicare Ltd

SHILPAMED
₹849.15-5.72%20 Nov 2026
Reports
Pharma API

Shilpa Medicare Ltd

SHILPAMED
₹849.15
-5.72%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹16,608Cr
Close
Close Price
₹849.15
Industry
Industry
Pharma API
PE
Price To Earnings
49.95
PS
Price To Sales
9.02
Revenue
Revenue
₹1,842Cr
Rev Gr TTM
Revenue Growth TTM
37.32%
PAT Gr TTM
PAT Growth TTM
142.21%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
287292293344319331321370410437466529
Growth YoY
Revenue Growth YoY%
9.210.712.49.811.313.49.97.628.532.144.943.0
Expenses
ExpensesCr
221222219258239252230262295317330387
Operating Profit
Operating ProfitCr
66707486817992108115120136142
OPM
OPM%
23.124.025.125.025.323.928.529.328.027.429.326.9
Other Income
Other IncomeCr
18652-2162-134598
Interest Expense
Interest ExpenseCr
262424261214191611141213
Depreciation
DepreciationCr
272727282929293030313534
PBT
PBTCr
14282937421550646112098104
Tax
TaxCr
9315191013201613-324
PAT
PATCr
5251418321547444510810179
Growth YoY
PAT Growth YoY%
171.0404.01,091.51,042.7576.2-40.8233.5145.740.3642.9115.179.7
NPM
NPM%
1.68.44.85.29.94.414.611.910.924.721.715.0
EPS
EPS₹
0.31.40.70.91.60.42.42.82.35.55.24.0
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
287292293344319331321370410437466529
Growth YoY
Revenue Growth YoY%
9.210.712.49.811.313.49.97.628.532.144.943.0
Expenses
ExpensesCr
221222219258239252230262295317330387
Operating Profit
Operating ProfitCr
66707486817992108115120136142
OPM
OPM%
23.124.025.125.025.323.928.529.328.027.429.326.9
Other Income
Other IncomeCr
18652-2162-134598
Interest Expense
Interest ExpenseCr
262424261214191611141213
Depreciation
DepreciationCr
272727282929293030313534
PBT
PBTCr
14282937421550646112098104
Tax
TaxCr
9315191013201613-324
PAT
PATCr
5251418321547444510810179
Growth YoY
PAT Growth YoY%
171.0404.01,091.51,042.7576.2-40.8233.5145.740.3642.9115.179.7
NPM
NPM%
1.68.44.85.29.94.414.611.910.924.721.715.0
EPS
EPS₹
0.31.40.70.91.60.42.42.82.35.55.24.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
7167797897339089011,1461,0501,1521,2861,5391,842
Growth
Revenue Growth%
16.78.81.2-7.023.8-0.827.1-8.39.711.719.637.3
Expenses
ExpensesCr
5566086275786887199429489079671,1041,329
Operating Profit
Operating ProfitCr
160171162156220182204102245319435513
OPM
OPM%
22.322.020.621.324.220.217.89.721.224.828.327.9
Other Income
Other IncomeCr
7914261789191410-93949
Interest Expense
Interest ExpenseCr
4334522415992765949
Depreciation
DepreciationCr
2331374244548096108113120130
PBT
PBTCr
140146137136188195102-3854122295383
Tax
TaxCr
36423426334942-722445250
PAT
PATCr
10510410311015514661-313278243332
Growth
PAT Growth%
44.2-0.3-1.56.541.1-5.4-58.6-151.1203.2145.0210.8142.2
NPM
NPM%
14.613.413.014.917.016.25.3-3.02.86.115.818.1
EPS
EPS₹
7.06.66.56.99.69.13.6-1.91.82.012.417.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
7167797897339089011,1461,0501,1521,2861,5391,842
Growth
Revenue Growth%
16.78.81.2-7.023.8-0.827.1-8.39.711.719.637.3
Expenses
ExpensesCr
5566086275786887199429489079671,1041,329
Operating Profit
Operating ProfitCr
160171162156220182204102245319435513
OPM
OPM%
22.322.020.621.324.220.217.89.721.224.828.327.9
Other Income
Other IncomeCr
7914261789191410-93949
Interest Expense
Interest ExpenseCr
4334522415992765949
Depreciation
DepreciationCr
2331374244548096108113120130
PBT
PBTCr
140146137136188195102-3854122295383
Tax
TaxCr
36423426334942-722445250
PAT
PATCr
10510410311015514661-313278243332
Growth
PAT Growth%
44.2-0.3-1.56.541.1-5.4-58.6-151.1203.2145.0210.8142.2
NPM
NPM%
14.613.413.014.917.016.25.3-3.02.86.115.818.1
EPS
EPS₹
7.06.66.56.99.69.13.6-1.91.82.012.417.0
Sales CAGR
1 Year20%
3 Years14%
5 Years11%
TTM37%
EBITDA CAGR
1 Year36%
3 Years62%
5 Years19%
TTM43%
PAT CAGR
1 Year211%
3 Years-
5 Years11%
TTM142%
Avg. ROCE
1 Year11%
3 Years8%
5 Years6%
TTM13%
CFO / EBITDA
1 Year79%
3 Years61%
5 Years69%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
888888999102020
Reserves
ReservesCr
6329791,0771,1891,3211,4711,8141,7751,8002,3532,5722,738
Current Liabilities
Current LiabilitiesCr
2222372662534116046127846936748481,017
Non Current Liabilities
Non Current LiabilitiesCr
67251153167257561453345600273266363
Total Liabilities
Total LiabilitiesCr
9311,4721,4991,6101,9892,6322,8762,9043,0933,3113,7064,138
Current Assets
Current AssetsCr
3547306725456249038877708779851,1101,277
Non Current Assets
Non Current AssetsCr
5777428271,0651,3651,7301,9882,1342,2162,3262,5962,860
Total Assets
Total AssetsCr
9311,4721,4991,6101,9892,6322,8762,9043,0933,3113,7064,138
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
888888999102020
Reserves
ReservesCr
6329791,0771,1891,3211,4711,8141,7751,8002,3532,5722,738
Current Liabilities
Current LiabilitiesCr
2222372662534116046127846936748481,017
Non Current Liabilities
Non Current LiabilitiesCr
67251153167257561453345600273266363
Total Liabilities
Total LiabilitiesCr
9311,4721,4991,6101,9892,6322,8762,9043,0933,3113,7064,138
Current Assets
Current AssetsCr
3547306725456249038877708779851,1101,277
Non Current Assets
Non Current AssetsCr
5777428271,0651,3651,7301,9882,1342,2162,3262,5962,860
Total Assets
Total AssetsCr
9311,4721,4991,6101,9892,6322,8762,9043,0933,3113,7064,138

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
129374514712447105180137132342
Investing Cash Flow
Investing Cash FlowCr
-109-262-9-196-290-404-286-233-167-199-326
Financing Cash Flow
Financing Cash FlowCr
-20313-61101764368346476314
Net Cash Flow
Net Cash FlowCr
088-25-391079-98-717-430
Free Cash Flow
Free Cash FlowCr
14-79-9369-220-303-226-46-48-111-28
CFO To PAT
CFO To PAT%
122.935.943.7134.080.532.1173.5-580.9427.7168.9140.6
CFO To EBITDA
CFO To EBITDA%
80.421.927.794.256.625.851.6175.955.941.478.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
129374514712447105180137132342
Investing Cash Flow
Investing Cash FlowCr
-109-262-9-196-290-404-286-233-167-199-326
Financing Cash Flow
Financing Cash FlowCr
-20313-61101764368346476314
Net Cash Flow
Net Cash FlowCr
088-25-391079-98-717-430
Free Cash Flow
Free Cash FlowCr
14-79-9369-220-303-226-46-48-111-28
CFO To PAT
CFO To PAT%
122.935.943.7134.080.532.1173.5-580.9427.7168.9140.6
CFO To EBITDA
CFO To EBITDA%
80.421.927.794.256.625.851.6175.955.941.478.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,3015,0943,7912,7741,9932,7213,4471,9914,0056,4846,81916,608
Price To Earnings
Price To Earnings
32.147.336.024.712.818.456.8125.782.828.050.0
Price To Sales
Price To Sales
4.66.54.83.82.23.03.01.93.55.04.49.0
Price To Book
Price To Book
5.15.23.52.31.51.81.91.12.22.72.66.0
EV To EBITDA
EV To EBITDA
21.030.523.918.310.419.020.127.120.122.117.133.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.945.647.555.160.759.656.549.355.759.060.860.8
OPM
OPM%
22.322.020.621.324.220.217.89.721.224.828.327.9
NPM
NPM%
14.613.413.014.917.016.25.3-3.02.86.115.818.1
ROCE
ROCE%
20.212.311.110.211.69.35.70.85.36.710.912.6
ROE
ROE%
16.410.69.59.111.69.93.3-1.71.83.39.412.1
ROA
ROA%
11.37.16.96.87.85.52.1-1.11.02.46.68.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,3015,0943,7912,7741,9932,7213,4471,9914,0056,4846,81916,608
Price To Earnings
Price To Earnings
32.147.336.024.712.818.456.8125.782.828.050.0
Price To Sales
Price To Sales
4.66.54.83.82.23.03.01.93.55.04.49.0
Price To Book
Price To Book
5.15.23.52.31.51.81.91.12.22.72.66.0
EV To EBITDA
EV To EBITDA
21.030.523.918.310.419.020.127.120.122.117.133.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.945.647.555.160.759.656.549.355.759.060.860.8
OPM
OPM%
22.322.020.621.324.220.217.89.721.224.828.327.9
NPM
NPM%
14.613.413.014.917.016.25.3-3.02.86.115.818.1
ROCE
ROCE%
20.212.311.110.211.69.35.70.85.36.710.912.6
ROE
ROE%
16.410.69.59.111.69.93.3-1.71.83.39.412.1
ROA
ROA%
11.37.16.96.87.85.52.1-1.11.02.46.68.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr17,68917,66916,60811,47010,2728,9845,751
Close PriceClose₹462.301,436.90849.15548.201,598.60990.70960.40
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE372.8226.3549.9541.0375.8034.99134.70
Price To SalesPS8.586.589.029.8011.824.164.71
RevenueRevenueCr2,0632,6841,8421,1708692,1611,221
Revenue Growth TTMRev Gr TTM%-21.3%8.2%37.3%4.0%13.4%20.1%
PAT Growth TTMPAT Gr TTM%-101.5%26.3%142.2%-13.6%7.1%16.5%
Market CapitalizationMkt CapCr17,68917,66916,60811,47010,2728,9845,751
Close PriceClose₹462.301,436.90849.15548.201,598.60990.70960.40
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE372.8226.3549.9541.0375.8034.99134.70
Price To SalesPS8.586.589.029.8011.824.164.71
RevenueRevenueCr2,0632,6841,8421,1708692,1611,221
Revenue Growth TTMRev Gr TTM%-21.3%8.2%37.3%4.0%13.4%20.1%
PAT Growth TTMPAT Gr TTM%-101.5%26.3%142.2%-13.6%7.1%16.5%
Interviews